SCHEMBL30079271

SCHEMBL30079271

CCOC(=O)c1cncnc1C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
ALDH1A1 P00352 6/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 3/20 0.41
HSP90AA1 P07900 1/20 0.40
KDM4E B2RXH2 4/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
LMNA P02545 2/20 0.39
MAPK1 P28482 2/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.39
RECQL P46063 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20337653 0.86 TSHR (0.42) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1752108 0.82 KDM4E (0.40) TSHRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL29906642 0.80 TSHR (0.48) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1669584 0.80 TSHR (0.48) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL7844021 0.79 TSHR (0.47) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL31351961 0.79 TSHR (0.47) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2327456 0.79 TSHR (0.47) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL23143261 0.78 TSHR (0.46) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2217314 0.78 ALDH1A1 (0.49) TSHRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL8682515 0.78 HSP90AA1 (0.49) TSHRALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed